| 375 | 2022 MIPS Measure #375: Functional Status Assessment for Total Knee Replacement | eCQM | Percentage of patients 18 years of age and older who received an elective primary total hip arthroplasty (THA) and completed a functional status assessment within 90 days prior to the surgery and in the 270-365 days after the surgery | Details | | |
| 472 | 2022 MIPS Measure #472: Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture | eCQM | Percentage of female patients 50 to 64 years of age without select risk factors for osteoporotic fracture who received an order for a dual-energy x-ray absorptiometry (DXA) scan during the measurement period | Details | | |
| 009 | 2022 MIPS Measure #9: Anti-depressant Medication Management | eCQM | Percentage of patients 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression, and who remained on an antidepressant medication treatment. Two rates are reported. | Details | | |
| 281 | 2022 MIPS Measure #281: Dementia: Cognitive Assessment | eCQM | Percentage of patients, regardless of age, with a diagnosis of dementia for whom an assessment of cognition is performed and the results reviewed at least once within a 12-month period | Details | | |
| 382 | 2022 MIPS Measure #382: Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment | eCQM | Percentage of patient visits for those patients aged 6 through 17 years with a diagnosis of major depressive disorder with an assessment for suicide risk | Details | | |
| 379 | 2022 MIPS Measure #379: Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists | eCQM | Percentage of children, 6 months - 20 years of age, who received a fluoride varnish application during the measurement period | Details | | |
| 378 | 2022 MIPS Measure #378: Children Who Have Dental Decay or Cavities | eCQM | Percentage of children, 6 months - 20 years of age at the start of the measurement period, who have had tooth decay or cavities during the measurement period | Details | | |
| 318 | 2022 MIPS Measure # 318: Falls: Screening for Future Fall Risk | eCQM | Percentage of patients 65 years of age and older who were screened for future fall risk during the measurement period | Details | | |
| 107 | 2022 MIPS Measure #107: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment | eCQM | All patient visits during which a new diagnosis of MDD or a new diagnosis of recurrent MDD was identified for patients aged 18 years and older with a suicide risk assessment completed during the visit | Details | | |
| TBD | 2022 MIPS Measure # TBD: Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer | eCQM | Percentage of patients initially diagnosed with non-muscle invasive bladder cancer and who received intravesical Bacillus-Calmette-Guerin (BCG) within 6 months of bladder cancer staging. | Details | | |
| 310 | 2022 MIPS Measure #310: Chlamydia Screening for Women | eCQM | Percentage of women 16-24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement period | Details | | |
| 239 | 2022 MIPS Measure #239: Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents | eCQM | Percentage of patients 3-17 years of age who had an outpatient visit with a Primary Care Physician (PCP) or Obstetrician/Gynecologist (OB/GYN) and who had evidence of the following during the measurement period. | Details | | |
| 012 | 2022 MIPS Measure #12: Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation | eCQM | Percentage of patients aged 18 years and older with a diagnosis of primary open-angle glaucoma (POAG) who have an optic nerve head evaluation during one or more visits within 12 months | Details | | |
| 476 | 2022 MIPS Measure #476: Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia | eCQM | Percentage of patients with an office visit within the measurement period and with a new diagnosis of clinically significant Benign Prostatic Hyperplasia who have International Prostate Symptoms Score (IPSS) or American Urological Association (AUA) Symptom Index (SI) documented at time of diagnosis and again 6-12 months later with an improvement of 3 points | Details | | |
| 475 | 2022 MIPS Measure #475: HIV Screening | eCQM | Percentage of patients aged 15-65 at the start of the measurement period who were between 15-65 years old when tested for HIV | Details | | |
| 376 | 2022 MIPS Measure #376: Functional Status Assessment for Total Hip Replacement | eCQM | Percentage of patients 18 years of age and older who received an elective primary total knee arthroplasty (TKA) and completed a functional status assessment within 90 days prior to the surgery and in the 270-365 days after the surgery | Details | | |
| 366 | 2022 MIPS Measure #366: Follow-Up Care for Children Prescribed ADHD Medication (ADD) | eCQM | Percentage of children 6-12 years of age and newly dispensed a medication for attention-deficit/hyperactivity disorder (ADHD) who had appropriate follow-up care. Two rates are reported. | Details | | |
